US Broker Ratings

ANI Pharmaceuticals (ANIP) Stock Analysis: A Compelling 47% Upside Potential Awaits Investors

For investors seeking opportunities in the healthcare sector, ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) presents a compelling case. With a potential upside of 47.07%, as indicated by analysts’ average target price,..

Adaptive Biotechnologies Corp (ADPT) Stock Analysis: Unveiling a 29% Upside Potential for Savvy Investors

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a pioneering entity in the biotechnology sector, is garnering attention with its robust 29.39% potential upside, according to recent analyst ratings. With its headquarters nestled..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Exploring a 44.65% Potential Upside in the Biotech Sector

Travere Therapeutics, Inc. (NASDAQ: TVTX), a prominent player in the biotechnology sector, is capturing investor attention with a remarkable potential upside of 44.65% based on current analyst ratings. This San..

Haemonetics Corporation (HAE) Stock Analysis: Exploring a 37.76% Potential Upside

Haemonetics Corporation (NYSE: HAE), a prominent player in the medical devices industry, is capturing investor attention with a compelling potential upside of 37.76%. Known for its innovative suite of hospital..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Navigating a 38.97% Potential Upside Amid Biotech Challenges

Investors eyeing the healthcare sector may find ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) an intriguing prospect. With a market capitalization of $3.86 billion, ACADIA stands as a significant player in the..

Twist Bioscience Corporation (TWST) Stock Analysis: A Look at the 8.71% Potential Upside in the Healthcare Sector

Twist Bioscience Corporation (NASDAQ: TWST) is making waves in the healthcare sector, specifically within the diagnostics and research industry, as it continues to capture the interest of investors with its..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Strong Buy Ratings and a Promising 14.42% Upside Potential

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a biotechnology firm specializing in peptide-based therapeutics, is capturing investor attention with its dynamic pipeline and robust analyst support. With a market capitalization of $6.01..

Premier, Inc. (PINC) Stock Analysis: Navigating a Stable Yet Cautious Path in Healthcare

Premier, Inc. (NASDAQ: PINC) stands as a notable player in the healthcare sector, specifically within the health information services industry. With a market capitalization of $2.34 billion, Premier, Inc. operates..

QuidelOrtho Corporation (QDEL) Stock Analysis: Potential Upside of Over 50% Amidst Strategic Positioning in Healthcare

QuidelOrtho Corporation (NASDAQ: QDEL) is a compelling entity within the healthcare sector, focusing on medical devices. With a market capitalization of $1.54 billion, the company specializes in diagnostic testing solutions,..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Anticipating a 40% Upside with Strong Buy Ratings

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a promising player in the biotechnology sector, is garnering attention from investors with its significant 40.35% potential upside, as indicated by current analyst target prices...

SS Innovations International (SSII) Stock Analysis: Unpacking the 192.5% Revenue Growth in the Healthcare Sector

In the dynamic landscape of the healthcare sector, India-based SS Innovations International Inc. (SSII) is making waves with its impressive revenue growth. The company, operating in the medical devices industry,..

Surgery Partners, Inc. (SGRY) Stock Analysis: A 60% Upside Potential Amidst Healthcare Growth

Surgery Partners, Inc. (NASDAQ: SGRY), a key player in the healthcare sector, presents a compelling opportunity for investors seeking exposure to the medical care facilities industry. With a robust market..

ARS Pharmaceuticals, Inc. (SPRY): Analyst Consensus Sees 214% Upside Potential

Investors eyeing opportunities in the biotechnology sector may want to take a closer look at ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a promising player focusing on innovative treatments for severe allergic..

Schrodinger, Inc. (SDGR) Stock Analysis: Investors Eye a Potential 93% Upside Amid Market Turbulence

Schrodinger, Inc. (NASDAQ: SDGR) is capturing investor attention with a compelling potential upside of 93.42%, according to recent analyst ratings. As a prominent player in the healthcare sector, specifically within..

Artivion, Inc. (AORT) Stock Analysis: Exploring a 33% Upside Potential in the Medical Device Sector

Artivion, Inc. (AORT), a prominent player in the healthcare sector specializing in medical devices, has been attracting investor attention with its diverse product range and promising market valuation. Headquartered in..

Concentra Group Holdings Parent (CON) Stock Analysis: 20% Upside Potential with Strong Buy Ratings

For investors eyeing opportunities in the healthcare sector, Concentra Group Holdings Parent, Inc. (CON) presents an intriguing proposition. With a market capitalization of $3.04 billion, the company is a significant..

Indivior Pharmaceuticals, Inc. (INDV): Investor Outlook with 45% Potential Upside

Indivior Pharmaceuticals, Inc. (NASDAQ: INDV) has emerged as a compelling entity within the healthcare sector, particularly in the highly specialized space of drug manufacturing for opioid dependency treatment. With a..

GeneDx Holdings Corp. (WGS): Analyst Ratings Signal a Promising 111% Upside

GeneDx Holdings Corp. (NASDAQ: WGS), a prominent player in the healthcare sector, particularly in the diagnostics and research industry, has captured the attention of investors with its compelling growth trajectory..

Azenta, Inc. (AZTA) Stock Analysis: Unveiling a 49.64% Potential Upside in the Healthcare Sector

For those attuned to investment opportunities in the healthcare sector, Azenta, Inc. (NASDAQ: AZTA) presents a fascinating narrative. With its strategic focus on providing cutting-edge sample management solutions and multiomics..

CONMED Corporation (CNMD) Investor Outlook: Exploring the Growth Potential and Analyst Consensus

CONMED Corporation (NASDAQ: CNMD), a prominent player in the healthcare sector, specifically within the medical devices industry, presents a compelling case for investors looking to capitalize on growth within the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds